{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=No+Therapy+6+Weeks&page=13", "query": { "intervention": "No Therapy 6 Weeks", "page": 13 }, "page_size": 10 }, "pagination": { "page": 13, "page_size": 10, "total_count": 1055, "total_pages": 106, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=No+Therapy+6+Weeks&page=14&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=No+Therapy+6+Weeks&page=12&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-13T22:37:10.361Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00049088", "title": "Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "docetaxel", "type": "DRUG" }, { "name": "bevacizumab", "type": "BIOLOGICAL" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "pharmacological study", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2002-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-01-24", "last_synced_at": "2026-10-13T22:37:10.361Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00049088" }, { "nct_id": "NCT02215200", "title": "ATG-GCSF in New Onset Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 1" ], "interventions": [ { "name": "Anti-Thymocyte Globulin (ATG)", "type": "DRUG" }, { "name": "Granulocyte colony stimulating factor (GCSF)", "type": "DRUG" }, { "name": "Placebo (for ATG)", "type": "DRUG" }, { "name": "Placebo (for GCSF)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "12 Years to 45 Years" }, "enrollment_count": 89, "start_date": "2014-12", "completion_date": "2018-08", "has_results": true, "last_update_posted_date": "2020-03-02", "last_synced_at": "2026-10-13T22:37:10.361Z", "location_count": 13, "location_summary": "San Francisco, California • Stanford, California • Aurora, Colorado + 10 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02215200" }, { "nct_id": "NCT01846611", "title": "A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ovarian Neoplasms", "Peritoneal Neoplasms", "Fallopian Tube Neoplasms" ], "interventions": [ { "name": "Trabectedin", "type": "DRUG" }, { "name": "DOXIL", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 581, "start_date": "2013-10-16", "completion_date": "2018-11-16", "has_results": true, "last_update_posted_date": "2019-04-01", "last_synced_at": "2026-10-13T22:37:10.361Z", "location_count": 75, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 72 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sedona", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01846611" }, { "nct_id": "NCT01011010", "title": "Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Liver Cancer" ], "interventions": [ { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "mitomycin C", "type": "DRUG" }, { "name": "sorafenib tosylate", "type": "DRUG" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "pharmacological study", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 11, "start_date": "2009-07-22", "completion_date": "2017-09-29", "has_results": false, "last_update_posted_date": "2018-01-05", "last_synced_at": "2026-10-13T22:37:10.361Z", "location_count": 2, "location_summary": "Chapel Hill, North Carolina • Winston-Salem, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01011010" }, { "nct_id": "NCT05045950", "title": "Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Brain Metastases" ], "interventions": [ { "name": "Memantine -Twice Daily or Extended Release", "type": "DRUG" }, { "name": "WBRT utilizing the PRDR technique", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Medical College of Wisconsin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 53, "start_date": "2021-11-17", "completion_date": "2029-05", "has_results": false, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-10-13T22:37:10.361Z", "location_count": 2, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05045950" }, { "nct_id": "NCT04199117", "title": "Health Systems Reach Interventions Project", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Smoking, Cigarette", "Smoking Cessation" ], "interventions": [ { "name": "Varenicline", "type": "DRUG" }, { "name": "Combination nicotine patch and nicotine mini-lozenge treatment", "type": "DRUG" }, { "name": "Monetary incentives for initiating treatment", "type": "BEHAVIORAL" }, { "name": "Automated tailored outreach", "type": "BEHAVIORAL" }, { "name": "Care management", "type": "BEHAVIORAL" }, { "name": "Wisconsin Tobacco Quit Line referral", "type": "OTHER" }, { "name": "Primary care provider referral", "type": "OTHER" }, { "name": "Untailored outreach", "type": "BEHAVIORAL" }, { "name": "Multiple smoking cessation coaching calls", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "OTHER" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 210, "start_date": "2020-03-11", "completion_date": "2024-10-16", "has_results": true, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-13T22:37:10.361Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04199117" }, { "nct_id": "NCT01681589", "title": "Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Traumatic Brain Injury" ], "interventions": [ { "name": "Transcranial Direct Current Stimulator (TDCS)", "type": "DEVICE" }, { "name": "Control Group", "type": "DEVICE" }, { "name": "Healthy Control Group", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 40, "start_date": "2012-08", "completion_date": "2019-06", "has_results": true, "last_update_posted_date": "2020-08-21", "last_synced_at": "2026-10-13T22:37:10.361Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01681589" }, { "nct_id": "NCT02043678", "title": "Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostatic Neoplasms" ], "interventions": [ { "name": "Radium-223 dichloride (Xofigo, BAY88-8223)", "type": "DRUG" }, { "name": "Matching placebo (normal saline)", "type": "DRUG" }, { "name": "Abiraterone", "type": "DRUG" }, { "name": "Prednisone/Prednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 806, "start_date": "2014-03-30", "completion_date": "2024-02-08", "has_results": true, "last_update_posted_date": "2025-02-19", "last_synced_at": "2026-10-13T22:37:10.361Z", "location_count": 29, "location_summary": "Anchorage, Alaska • Tucson, Arizona • Oceanside, California + 25 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Oceanside", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02043678" }, { "nct_id": "NCT00762710", "title": "Study of the Medication Prazosin for Alcohol Dependence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcoholism" ], "interventions": [ { "name": "Prazosin medication", "type": "DRUG" }, { "name": "Placebo medication", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Seattle Institute for Biomedical and Clinical Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 92, "start_date": "2008-01", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2020-06-04", "last_synced_at": "2026-10-13T22:37:10.361Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00762710" }, { "nct_id": "NCT05926024", "title": "Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Exercise Recall Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Health Behavior Questionnaire (HBQ)30 Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Functional Assessment of Cancer Therapy-General (FACT-G) Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes PROMIS Cognitive Function (Short Form 8a)", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes Functional Assessment of Cancer-Gynecology Oncology Group-Neurotoxicity (FACT/GOG-NTX-12)", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes PROMIS", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes FACT-Endocrine Symptoms", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes Penn Arthralgia Aging Survey", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes PRO-CTCAE (patient-reported CTCAE)", "type": "BEHAVIORAL" }, { "name": "p16 tumor suppressor gene", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "BEHAVIORAL", "DIAGNOSTIC_TEST" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "FEMALE", "summary": "21 Years and older · Female only" }, "enrollment_count": 253, "start_date": "2023-01-06", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-10-13T22:37:10.361Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05926024" } ] }